Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Coagulation

Citations 111-120 of 166 total displayed.

Past content (since Sep 2000):

Cardiology Patient Pages
Antiplatelet Therapy
Robert A. Harrington, Patricia K. Hodgson, and Rhonda L. Larsen
Circulation 2003;108:e45-47e, doi:10.1161/01.CIR.0000083142.13956.D6 [Full text]  

Clinical Investigations and Reports
Prognostic Value of Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 994 Patients With Nonvalvular Atrial Fibrillation
Dwayne S.G. Conway, Lesly A. Pearce, Bernard S.P. Chin, Robert G. Hart, and Gregory Y.H. Lip
Circulation 2003;107:3141-3145; published online before print as doi:10.1161/01.CIR.0000077912.12202.FC [Abstract] [Full text]  

Clinical Investigations and Reports
Prognostic Value of Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 994 Patients With Nonvalvular Atrial Fibrillation
Dwayne S.G. Conway, Lesly A. Pearce, Bernard S.P. Chin, Robert G. Hart, and Gregory Y.H. Lip
Circulation published June 9, 2003, doi:10.1161/01.CIR.0000077912.12202.FC [Abstract] [Full text]  

Clinical Investigations and Reports
Functional Analysis of the Fibrinogen A{alpha} Thr312Ala Polymorphism: Effects on Fibrin Structure and Function
Kristina F. Standeven, Peter J. Grant, Angela M. Carter, Thomas Scheiner, John W. Weisel, and Robert A.S. Ariëns
Circulation 2003;107:2326-2330; published online before print as doi:10.1161/01.CIR.0000066690.89407.CE [Abstract] [Full text]  

Articles
Functional Analysis of the Fibrinogen A{alpha} Thr312Ala Polymorphism. Effects on Fibrin Structure and Function
Kristina F. Standeven, Peter J. Grant, Angela M. Carter, Thomas Scheiner, John W. Weisel, and Robert A.S. Ariëns
Circulation published April 21, 2003, doi:10.1161/01.CIR.0000066690.89407.CE [Abstract]  

Brief Rapid Communications
Aspirin Alters the Cardioprotective Effects of the Factor XIII Val34Leu Polymorphism
Anetta Undas, Wojciech J. Sydor, Kathleen Brummel, Jacek Musial, Kenneth G. Mann, and Andrew Szczeklik
Circulation 2003;107:17-20; published online before print as doi:10.1161/01.CIR.0000047062.03282.A3 [Abstract] [Full text]  

Clinical Investigations and Reports
Elevations of Inflammatory and Procoagulant Biomarkers in Elderly Persons With Renal Insufficiency
Michael G. Shlipak, Linda F. Fried, Casey Crump, Anthony J. Bleyer, Teri A. Manolio, Russell P. Tracy, Curt D. Furberg, and Bruce M. Psaty
Circulation 2003;107:87-92; published online before print as doi:10.1161/01.CIR.0000042700.48769.59 [Abstract] [Full text]  

Articles
Aspirin Alters the Cardioprotective Effects of the Factor XIII Val34Leu Polymorphism
Anetta Undas, Wojciech J. Sydor, Kathleen Brummel, Jacek Musial, Kenneth G. Mann, and Andrew Szczeklik
Circulation published December 2, 2002, doi:10.1161/01.CIR.0000047062.03282.A3 [Abstract]  

Articles
Elevations of Inflammatory and Procoagulant Biomarkers in Elderly Persons With Renal Insufficiency
Michael G. Shlipak, Linda F. Fried, Casey Crump, Anthony J. Bleyer, Teri A. Manolio, Russell P. Tracy, Curt D. Furberg, and Bruce M. Psaty
Circulation published December 2, 2002, doi:10.1161/01.CIR.0000042700.48769.59 [Abstract]  

Clinical Investigations and Reports
Ability of Recombinant Factor VIIa to Reverse the Anticoagulant Effect of the Pentasaccharide Fondaparinux in Healthy Volunteers
Nick R. Bijsterveld, Arno H. Moons, S. Matthijs Boekholdt, Benien E. van Aken, Hein Fennema, Ron J.G. Peters, Joost C.M. Meijers, Harry R. Büller, and Marcel Levi
Circulation 2002;106:2550-2554; published online before print as doi:10.1161/01.CIR.0000038501.87442.02 [Abstract] [Full text]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

* Subspecialty Collections Home

* Show  Coagulation
 collections from other journals.

* Related collections:
 Thrombosis
 Anticoagulant mechanisms
 Anticoagulants
 Arterial thrombosis
 Coagulation and fibronolysis
 Coagulation inhibitors
 Coagulation
 Deep vein thrombosis
 Fibrinogen/fibrin
 Fibrinolysis
 Platelet adhesion
 Platelet function inhibitors
 Platelets
 Thrombin
 Thrombophilia
 Thrombosis risk factors